Globus pallidus plays a critical role in neurotrophic factor induced functional improvements in hemiparkinsonian monkeys

Biochemical and Biophysical Research Communications

Volumn 370, Issue 3, 2008, Pages 434-439

  Xin, Tao ^a,b   Ai, Yi ^b   Gerhardt, Greg ^b   Gash, Don ^b   Zhang, Zhiming ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Dopamine; GDNF; Globus pallidus; ICV; Lesion; Monkey; MPTP; Neurotrophic factor; Parkinson's disease; Substantia nigra

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GLOBUS PALLIDUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NEUROIMAGING; NONHUMAN; OUTCOME ASSESSMENT; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RHESUS MONKEY; SUBSTANTIA NIGRA; TREATMENT OUTCOME; TREATMENT RESPONSE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLOBUS PALLIDUS; MACACA MULATTA; MPTP POISONING; NEUROTOXINS;

MACACA MULATTA;

EID: 42749090964     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.108     Document Type: Article

References (28)

1. Lang A.E., and Lozano A.M. Parkinson's disease. First of two parts. N. Engl. J. Med. 339 15 (1998) 1044-1053
2. Hornykiewicz O. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv. Neurol. 60 (1993) 140-147
3. Gash D.M., Zhang Z., Cass W.A., Ovadia A., Simmerman L., Martin D., Russell D., Collins F., Hoffer B.J., and Gerhardt G.A. Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys. J. Comp. Neurol. 363 (1995) 345-358
4. Maswood N., Grondin R., Zhang Z., Stanford J.A., Surgener S.P., Gash D.M., and Gerhardt G.A. Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys. Neurobiol. Aging 23 (2002) 881-889
5. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., and Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380 (1996) 252-255
6. Gash D.M., Zhang Z., Ai Y., Grondin R., Coffey R., and Gerhardt G.A. Trophic factor distribution predicts functional recovery in parkinsonian monkeys. Ann. Neurol. 58 (2005) 224-233
7. Grondin R., Zhang Z., Yi A., Cass W.A., Maswood N., Andersen A.H., Elsberry D.D., Klein M.C., Gerhardt G.A., and Gash D.M. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 125 (2002) 2191-2201
8. Smith Y., and Kieval J.Z. Anatomy of the dopamine system in the basal ganglia. Trends Neurosci. 23 10 Suppl (2000) S28-S33
9. Zhang Z., Zhang M., Ai Y., Avison C., and Gash D.M. MPTP-Induced pallidal lesions in rhesus monkeys. Exp. Neurol. 155 (1999) 140-149
10. Smith R.D., Zhang Z., Kurlan R., McDermott M., and Gash D.M. Developing a stable bilateral model of parkinsonism in rhesus monkeys. Neuroscience 52 (1993) 7-16
11. Ovadia A., Zhang Z., and Gash D.M. Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys. Neurobiol. Aging 16 6 (1995) 931-937
12. Zhang Z., Miyoshi Y., Lapchak P.A., Collins F., Hilt D., Lebel C., Kryscio R., and Gash D.M. Dose-response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys. J. Pharmacol. Exp. Ther. 282 (1997) 1396-1401
13. Kurlan R., Kim M.H., and Gash D.M. Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism. Mov. Disord. 6 2 (1991) 111-118
14. Gerhardt G.A., Cass W.A., Huettl P., Brock S., Zhang Z., and Gash D.M. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys. Brain Res. 817 (1999) 163-171
15. Ondo W.G., and Silay Y.S. Intravenous flumazenil for Parkinson's disease: a single dose, double blind, placebo controlled, cross-over trial. Mov. Disord. 21 10 (2006) 1614-1617
16. Mogilner A.Y., Sterio D., Rezai A.R., Zonenshayn M., Kelly P.J., and Beric A. Subthalamic nucleus stimulation in patients with a prior pallidotomy. J. Neurosurg. 96 (2002) 660-665
17. Kleiner-Fisman G., et al. Subthalamic nucleus deep brain stimulation for parkinson's disease after successful pallidotomy: clinical and electrophysiological observations. Mov. Disord. 19 10 (2004) 1209-1214
18. Yelnik J. Functional anatomy of the basal ganglia. Mov. Disord. 17 Suppl 3 (2002) S15-S21
19. Presa P., Pardo B.G., Martinez P., and Bernatchez L. Phylogeographic congruence between mtDNA and rDNA ITS markers in brown trout. Mol. Biol. Evol. 19 (2002) 2161-2175
20. Parent A., and Hazrati L.N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Brain Res. Rev. 20 (1995) 128-154
21. Parent A., Lavoie B., Smith Y., and Bedard P. The dopaminergic nigropallidal projection in primates: distinct cellular origin and relative sparing in MPTP-treated monkeys. Adv. Neurol. 53 (1990) 111-116
22. Schneider J.S., and Dacko S. Relative sparing of the dopaminergic innervation of the globus pallidus in monkeys made hemi-parkinsonian by intracarotid MPTP infusion. Brain Res. 556 2 (1991) 292-296
23. Rinvik E., and Ottersen O.P. Terminals of subthalamonigral fibres are enriched with glutamate-like immunoreactivity: an electron microscopic, immunogold analysis in the cat. J. Chem. Neuroanat. 6 1 (1993) 19-30
24. Hammond C., Deniau J.M., Rizk A., and Feger J. Electrophysiological demonstration of an excitatory subthalamonigral pathway in the rat. Brain Res. 151 (1978) 235-244
25. DeLong M.R., Crutcher M.D., and Georgopoulos A.P. Primate globus pallidus and subthalamic nucleus: functional organization. J. Neurophysiol. 53 2 (1985) 530-543
26. Fink-Jensen A., and Mikkelsen J.D. A direct neuronal projection from the entopeduncular nucleus to the globus pallidus. A PHA-L anterograde tracing study in the rat. Brain Res. 542 1 (1991) 175-179
27. Matsumura M., Sawaguchi T., and Kubota K. GABAergic inhibition of neuronal activity in the primate motor and premotor cortex during voluntary movement. J. Neurophysiol. 68 (1992) 692-702
28. Obeso J.A., Rodriguez-Oroz M.C., Rodriguez M., Macias R., Alvarez L., Guridi J., Vitek J., and DeLong M.R. Pathophysiologic basis of surgery for Parkinson's disease. Neurology 55 (2000) S7-S12